Jane Huang, CMO, Hematology at BeiGene, Ltd. (BGNE), sold 40,902 shares at $330.53 ($13.6M) on 2021-07-15, disclosed to the SEC on 2021-07-19.
Open-market sale of $13.6M BGNE by CMO, Hematology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $330.53 | 2,379 | $786K | 5.8% |
| 2 | $330.53 | 2,379 | $786K | 5.8% |
| 3 | $331.79 | 6,523 | $2.2M | 15.9% |
| 4 | $331.79 | 6,523 | $2.2M | 15.9% |
| 5 | $332.71 | 8,177 | $2.7M | 20.0% |
| 6 | $332.71 | 8,177 |
| $2.7M |
| 20.0% |
| 7 | $333.64 | 2,823 | $942K | 6.9% |
| 8 | $333.64 | 2,823 | $942K | 6.9% |
| 9 | $334.85 | 1,000 | $335K | 2.5% |
| 10 | $335.76 | 98 | $33K | 0.2% |
| Total | $332.35 avg | 40,902 | $13.6M | 100% |
| Filing → |
| BGNE | SELL | 2021-12-02 | $755K | — | Filing → |
| BGNE | SELL | 2021-11-19 | $572K | — | Filing → |
| BGNE | SELL | 2021-10-21 | $559K | — | Filing → |